ArticleAge and ageing2026
Primary care-based post diagnostic dementia care in England: modelling and scaling up evidence-based models for efficient future care.
Article in Age and ageing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe global prevalence of dementia is rising rapidly, placing increasing pressure on health and social care systems to deliver coordinated and equitable post-diagnostic support. In England, service fragmentation and workforce constraints limit the delivery of recommended care models. Non-clinical dementia navigator (DN) models have emerged as a potentially scalable approach to improve care coordination and access, yet evidence on their system-level impact remains limited.
methodsWe estimated the population of people with diagnosed dementia in England eligible for DN support between 2025 and 2030 using NHS data and projected prevalence trends. Eligibility was adjusted for undiagnosed cases, care home residents, and expected uptake. Costs of delivering DN-led care were derived from existing UK service models and unit costs, while potential savings were based on reductions in health-care utilisation observed in the US Care Ecosystem trial. Probabilistic sensitivity analyses were conducted to assess uncertainty.
resultsThe number of eligible individuals receiving DN support is projected to increase from 300 000 in 2025 to 360 000 in 2030. Delivering this model would require ~940 to 1120 link workers. Annual costs are estimated at £224 million in 2025, rising to £343 million in 2030. These are offset by estimated savings of £1140 million and £1750 million, respectively. Even under conservative assumptions, DN models generate net savings.
conclusionsScaling up DN-led care in England could support large numbers of people with dementia while generating substantial health system savings. These findings suggest that navigator-based models offer a feasible and cost-saving approach to delivering coordinated post-diagnostic dementia care at scale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.